If completed, the deal could allow Medtronic to shift its tax base overseas, people familiar with the events told Bloomberg. Medtronic's moves for a bid are in an early stage and no offer is pending, the people said.
Spokesmen for Medtronic, based in Minneapolis, and Smith & Nephew declined to comment.
Another U.S. medical device company, Stryker, is also considering a bid for Smith & Nephew, Bloomberg said. Last week, in response to a Financial Times report, Stryker's Chief Executive, Kevin Lobo, said the company was in the early stages of evaluating a bid, according to the Bloomberg article.
Read the full story here.